| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000240288.3 |
Palbociclib |
Esophageal cancer |
0.019792812 |
Resistant |
| ENSG00000240288.3 |
Palbociclib |
Sarcoma |
0.037630143 |
Resistant |
| ENSG00000240288.3 |
Palbociclib |
Bladder urothelial carcinoma |
0.022461832 |
Sensitive |
| ENSG00000240288.3 |
Palbociclib |
Stomach adenocarcinoma |
0.017363519 |
Sensitive |
